|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003873,
umls-concept:C0008976,
umls-concept:C0025677,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0087111,
umls-concept:C0205177,
umls-concept:C0205390,
umls-concept:C0393022,
umls-concept:C1274040
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-5-9
|
|
pubmed:abstractText |
To examine the efficacy and safety of different rituximab doses plus methotrexate (MTX), with or without glucocorticoids, in patients with active rheumatoid arthritis (RA) resistant to disease-modifying antirheumatic drugs (DMARDs), including biologic agents.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
pubmed-author:AgarwalSunilS,
pubmed-author:DANCER Study Group,
pubmed-author:EmeryPaulP,
pubmed-author:Filipowicz-SosnowskaAnnaA,
pubmed-author:FleischmannRoyR,
pubmed-author:HesseyEva WEW,
pubmed-author:KavanaughArthurA,
pubmed-author:LiNicole FNF,
pubmed-author:RacewiczArtur JAJ,
pubmed-author:SchechtmanJoyJ,
pubmed-author:ShawTimothy MTM,
pubmed-author:SzczepanskiLeszekL,
pubmed-author:van VollenhovenRonald FRF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1390-400
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16649186-Antibodies, Monoclonal,
pubmed-meshheading:16649186-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:16649186-Antirheumatic Agents,
pubmed-meshheading:16649186-Arthritis, Rheumatoid,
pubmed-meshheading:16649186-Double-Blind Method,
pubmed-meshheading:16649186-Drug Resistance,
pubmed-meshheading:16649186-Drug Therapy, Combination,
pubmed-meshheading:16649186-Female,
pubmed-meshheading:16649186-Glucocorticoids,
pubmed-meshheading:16649186-Humans,
pubmed-meshheading:16649186-Immunologic Factors,
pubmed-meshheading:16649186-Male,
pubmed-meshheading:16649186-Methotrexate,
pubmed-meshheading:16649186-Middle Aged,
pubmed-meshheading:16649186-Safety
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial.
|
|
pubmed:affiliation |
Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK. p.emery@leeds.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
